πŸ‡ΊπŸ‡Έ FDA
Patent

US 11597701

Integrin ligands and uses thereof

granted A61KA61K31/44A61K31/7088

Quick answer

US patent 11597701 (Integrin ligands and uses thereof) held by Arrowhead Pharmaceuticals, Inc. expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arrowhead Pharmaceuticals, Inc.
Grant date
Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/44, A61K31/7088, A61K31/713, A61K47/545